Table 3.
Parameters | Group 1 (n=12) | Group 2 (n=9) | P-value |
---|---|---|---|
Age (years) | 65 (31–79)* | 67 (44–80) | 0.859 |
Duration of disease (months) | 23 (4–240) | 54 (8–207) | 0.394 |
WBC/µl | 7.8 (5.2–17.6) | 8.7 (3.8–12.2) | 0.394 |
Lymphocyte count/mm3 | 2062 (928–11 616) | 2871 (1078–6588) | 0.887 |
Eosinophils/mm3 | 388 (61–1545) | 87 (0–351) | 0.008 |
Sézary cells/100 lymphocytes | 32 (0–51) | 54 (36–85) | 0.001 |
Sézary cells/mm3 | 657 (0–5576) | 2010 (496–5039) | 0.155 |
%CD4+ cells | 83 (42–98) | 85 (38–92) | 0.499 |
CD4+ (cells/mm3) | 1585 (390–11 384) | 2268 (523–5863) | 0.943 |
%CD8+ cells | 6.5 (0.5–24) | 5 (1–45) | 0.887 |
CD8+ (cells/mm3) | 118 (58–447) | 154 (24–1279) | 0.887 |
CD4/CD8 ratio | 12.4 (1.8–196) | 17.0 (1.2–88) | 0.522 |
LDH (U/l) | 208 (170–336) | 248 (161–602) | 0.355 |
IgE (U/l) | 92 (2–2716) | 35 (5–630) | 0.434 |
IL-5 (pg/ml) | 0.06 (0–0.18)† | 0 (0–0.21) | 0.345 |
IL-10 (pg/ml) | 0.14 (0–30.02)† | 0.63 (0–3.21) | 0.504 |
IL-12 (pg/ml) | 0.06 (0–12.69)† | 0.01 (0–3.20) | 0.720 |
TNF-α (pg/ml) | 0.45 (0–1.34)† | 0.45 (0–4.78) | 0.626 |
Values given as median (range).
Patient 3 not studied.
LDH, lactate dehydrogenase; IL, interleukin.